With the aid of our modern processing unit, we are involved in offering our clients highly effective Erlotinib Tablet-100mg. Our offered tablets are effective for the treatment of patients with locally advanced or metastatic non-small cell lung cancer. These tablets are tested on well-defined parameters of quality at our vendors' end, in order to offer flawless products at the customers end. This Erlotinib Tablet-100mg is also effective for the treatment of patients with locally advanced, unresectable or metastatic pancreatic cancer.
Others, Cash Against Delivery (CAD)
Main Export Market(s)
Africa, Middle East, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia
"We are inviting inquiries only from South America, Africa, Middle East, Cih, South East Asia."
Disclaimer: Products protected under valid patents are not offered or supplied for commercial use. However, the research quantities of such products may be offered for the purpose of regulatory submissions, wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
FLAGSHIP BIOTECH INTERNATIONAL PVT. LTD.
1302, Rupa Solitaire, Millenium Business Park (MBP), Next to Hotel Ramada, Mahape, Navi Mumbai - 400710, Maharashtra, India